# Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo

> **NCT02506101** · NA · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 2 (actual)

## Conditions studied

- Vitiligo
- Pigmentation
- Dyschromia

## Interventions

- **DEVICE:** narrow-band ultraviolet B phototherapy

## Key facts

- **NCT ID:** NCT02506101
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07
- **Primary completion:** 2016-10-04
- **Final completion:** 2016-10-04
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Lack of enrollment and staff availability to administer treatment.
- **Last updated:** 2018-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02506101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02506101, "Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02506101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*